Insiders · Profile

Cook Jennifer E.

Director at BridgeBio Pharma · Director at Denali Therapeutics · Director at Jazz Pharmaceuticals. Filing since 2 Dec 2021. CIK 0001754371

Company
Date
Role
Action
Shares
Amount
Of holding
9 Jul 2026
Director
Sold on a plan
148,589
$13.16M
94.7%
24 Jun 2026
Director
Sold on a plan
37,167
$2.60M
81.6%
23 Jun 2026
Director
Sold on a plan
2,196
$150.58K
20.8%
15 Jun 2026
Director
Sold on a plan
90,240
$6.01M
93.2%
6 Jun 2024
Director
Sold on a plan
1,458
$31.68K
6.8%
4 Dec 2023
Director
Sold at will
417
$49.74K
5.7%
14 Aug 2023
Director
Sold at will
1,241
$171.45K
14.5%
2 Dec 2022
Director
Sold, plan not stated
420
$64.97K
7.1%
8 Aug 2022
Director
Sold, plan not stated
1,089
$165.88K
15.6%
2 Dec 2021
Director
Sold, plan not stated
417
$50.58K
8.6%
10 decisions on file.